The role of hypercoagulability in the development of osteonecrosis of the femoral head

被引:27
作者
Lykissas, Marios G. [1 ]
Gelalis, Ioannis D. [2 ]
Kostas-Agnantis, Ioannis P. [2 ]
Vozonelos, Georgios [2 ]
Korompilias, Anastasios V. [2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA
[2] Univ Ioannina, Sch Med, Dept Orthopaed Surg, Ioannina, Greece
关键词
osteonecrosis; femoral head; intravascular coagulation; hypercoagulability;
D O I
10.4081/or.2012.e17
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Despite the large number of the outstanding researches, pathogenesis of osteonecrosis remains unknown. During the last decades the hypothesis that increased intravascular coagulation may be the pathogenetic mechanism which leads to osteonecrosis is gaining constantly support. Both primary factors of hypercoagulability, such as resistance to activated protein C, protein C and protein S deficiency, low levels of tissue plasminogen activator, high levels of plasminogen activator inhibitor, von Willebrand factor, lipoprotein (a), and secondary factors of hypercoagulability with factors potentially activating intravascular coagulation, such as pregnancy, antiphospholipid antibodies, systemic lupus erythematosus, hemoglobinopathies and sickle cell disease, and hemato- oncologic diseases are discussed in this article. Although coagulation abnormalities in patients with hip osteonecrosis might represent increased risk factors for the development of bone necrosis by predisposing the patient to thromboembolic phenomena, further investigation is needed to indicate the definite correlation between factors leading to increased intravascular coagulation and pathogenesis of osteonecrosis.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 83 条
[1]   Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States [J].
Abbott, KC ;
Koff, J ;
Bohen, EM ;
Oglesby, RJ ;
Agodoa, LYC ;
Lentine, KL ;
Schnitzler, MA .
TRANSPLANTATION, 2005, 79 (03) :330-336
[2]   ASEPTIC NECROSIS OF BONE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP TO CORTICOSTEROID-THERAPY [J].
ABELES, M ;
URMAN, JD ;
ROTHFIELD, NF .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (05) :750-754
[3]  
[Anonymous], 1981, Lancet, V2, P384
[4]  
Arico M, 2003, HAEMATOLOGICA, V88, P747
[5]  
Arruda VR, 1999, J PEDIATR ORTHOPED, V19, P84
[6]  
ASHERSON RA, 1993, J RHEUMATOL, V20, P284
[7]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[8]  
ASHERSON RA, 1985, 16 INT C RHEUM SYDN, P282
[9]   Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors [J].
Badros, A ;
Weikel, D ;
Salama, A ;
Goloubeva, O ;
Schneider, A ;
Rapoport, A ;
Fenton, R ;
Gahres, N ;
Sausville, E ;
Ord, R ;
Meiller, T .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :945-952
[10]  
Berg K., 1990, LIPOPROTEIN A, P1